Literature DB >> 3550043

Diabetes: cataract extraction and intraocular lenses.

J J Alpar.   

Abstract

New findings concerning the use of anterior chamber angle-fixated lenses, especially with flexible loops, and posterior chamber lenses placed in the ciliary sulcus and in the bag reinforce previous findings that the safest procedure for diabetics is controlled extracapsular surgery with careful cleaning of the cortical material and in-the-bag implantation of a posterior chamber intraocular lens.

Entities:  

Mesh:

Year:  1987        PMID: 3550043     DOI: 10.1016/s0886-3350(87)80009-3

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  6 in total

Review 1.  The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.

Authors:  A J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  The course of diabetic retinopathy following cataract surgery in eyes previously treated by laser photocoagulation.

Authors:  A Pollack; H Leiba; A Bukelman; S Abrahami; M Oliver
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

3.  Cystoid macular oedema after extracapsular cataract extraction and intraocular lens implantation in diabetic patients without retinopathy.

Authors:  U Menchini; F Bandello; R Brancato; F I Camesasca; M Galdini
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

4.  Progression of diabetic retinopathy after cataract extraction.

Authors:  A Pollack; S Dotan; M Oliver
Journal:  Br J Ophthalmol       Date:  1991-09       Impact factor: 4.638

5.  Extracapsular cataract surgery with lens implantation in diabetics with and without proliferative retinopathy.

Authors:  I A Cunliffe; D W Flanagan; N D George; R J Aggarwaal; A T Moore
Journal:  Br J Ophthalmol       Date:  1991-01       Impact factor: 4.638

6.  Course of diabetic retinopathy following cataract surgery.

Authors:  A Pollack; S Dotan; M Oliver
Journal:  Br J Ophthalmol       Date:  1991-01       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.